← Leaderboards
John F Klement
Thomas Jefferson University
$301,808
Attributed
$301,808
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$301,808 · 4
By mechanism
R21$157,000 · 1
P01$144,808 · 3
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Jouni Uitto$17,268,454
- Steven B McMahon$11,125,471
- Olga Igoucheva$2,626,410
- Thomas B Knudsen$3,132,088
- Ya-Ming Hou$21,661,043
Others in their field
Top investigators on “Genetically Modified Animals”
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$42,971,897
- C Ronald Kahn · Joslin Diabetes Center$28,941,790
- Edward E Partridge · University Of Alabama At Birmingham$26,712,465
- Ronald B Corley · Boston University Medical Campus$26,592,975
- John T Potts · Massachusetts General Hospital$25,176,515
- Reisa A. Sperling · Banner Health$24,903,674
Research focus
Genetically Modified AnimalsLaboratory MouseGene TargetingPolymerase Chain ReactionModel Design /DevelopmentEpidermolysis BullosaDisease /Disorder ModelEmbryonic Stem CellBiomedical FacilityGene ExpressionSouthern BlottingWestern BlottingsSite Directed MutagenesisHistologyKeratinocyteLigandsMammalian EmbryologyAgingMolecular PathologyMolecular SiteNorthern BlottingsProgesteroneProtein Structure FunctionReporter Genes
Grant awards (9)
Novel Technologies For Skin-Specific Gene Expression$78,500
R21 · FY2003 · AR
Novel Technologies For Skin-Specific Gene Expression$78,500
R21 · FY2002 · AR
MOUSE MODELS OF EPIDERMOLYSIS BULLOSA$0
P01 · FY2002 · AR
CORE--ANIMAL$0
P01 · FY2002 · AR
Core--Transgenic mouse$0
P01 · FY2002 · AR
CORE--ANIMAL$0
P01 · FY2002 · AR
MOUSE MODELS OF EPIDERMOLYSIS BULLOSA$0
P01 · FY2002 · AR
CORE--ANIMAL MODELS OF EPIDERMOLYSIS BULLOSA$0
P01 · FY2001 · AR
CORE--ANIMAL MODELS OF EPIDERMOLYSIS BULLOSA$144,808
P01 · FY2000 · AR